Home/PleoPharma/Ginger Constantine, M.D.
GC

Ginger Constantine, M.D.

Chief Executive Officer, Co-Founder, Chairperson

PleoPharma

PleoPharma Pipeline

DrugIndicationPhase
Lead Program (Unnamed)Cannabis Use Disorder (CUD) / Cannabis Withdrawal Syndrome (CWS)Phase 2